Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

See Remarks

Chief Scientific Officer

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-10	Premium	bought	Premium	Premium	Premium	-
2024-03-18	Premium	acquired	Premium	Premium	Premium	-
2024-03-15	Premium	acquired	Premium	Premium	Premium	-
2024-03-15	Premium	acquired	Premium	Premium	Premium	-
2024-03-15	Premium	acquired	Premium	Premium	Premium	-
2024-03-14	Premium	bought	Premium	Premium	Premium	-
2024-01-31	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-31	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-31	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-31	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-31	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-11-27	Premium	bought	Premium	Premium	Premium	-
2023-11-20	Premium	bought	Premium	Premium	Premium	See Remarks
2023-11-20	Premium	bought	Premium	Premium	Premium	-
2023-11-17	Premium	bought	Premium	Premium	Premium	See Remarks
2023-11-16	Premium	bought	Premium	Premium	Premium	-
2023-11-14	Premium	bought	Premium	Premium	Premium	-
2023-08-09	Premium	bought	Premium	Premium	Premium	See Remarks
2023-06-07	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	acquired	Premium	Premium	Premium	-

XERS - Xeris Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for XERS